Accretion Nutraveda Ltd IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 908,000 (47%) | — | ₹1,171 Cr |
| NII (HNI) | — | 276,000 (14%) | — | ₹356 Cr |
| Retail | — | 640,000 (33%) | — | ₹826 Cr |
| Market Maker | — | 96,000 (5%) | — | ₹12 Cr |
| Σ Total | — | 1,920,000 (100%) | — | ₹24,768 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,000 | ₹129,000 |
| Retail (Max) | 13 | 13,000 | ₹1,677,000 |
| S-HNI (Min) | 14 | 14,000 | ₹1,806,000 |
| B-HNI (Min) | 67 | 67,000 | ₹8,643,000 |
Financial Statements Amount in ₹ Crore
| Metric | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Revenue | 14 | 16 | 5 |
| EBITDA | 3 | 4 | 1 |
| Profit After Tax | 2 | 3 | 1 |
| Net Worth | 8 | 5 | 1 |
| Total Assets | 16 | 11 | 5 |
| Reserves & Surplus | 3 | 5 | 1 |
| Total Borrowing | 4 | 4 | 2 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- Purchase of Machineries for Automation in existing Manufacturing unit – 4.22
- Purchase of Machineries for New Manufacturing Setup – 8.03
- Funding working capital requirements of our company – 5.50
- General corporate purposes –
Company Overview
Incorporated in 2021, Accretion Nutraveda is engaged in the manufacturing of Ayurvedic and Nutraceutical products in various dosage forms, including tablets, capsules, oral liquids, powders, oils, and external preparations like balms, creams, and gels.
The company operates as a Contract Development and Manufacturing Organization (CDMO), serving both domestic and international markets such as Sri Lanka, Singapore, and the USA. Its products combine classical Ayurvedic principles with modern nutraceutical science to address areas like liver care, women’s health, bone and joint health, cognitive support, and respiratory wellness.
Business verticals:
- Domestic Sales & Merchant Exports (Loan License Basis)– contributing 96.62% of total revenue in FY 2024-25.
- Direct Exports– Contributing 38%, showing consistent growth.
It has a manufacturing facility in Gujarat covers about 10,763 sq. ft., equipped with modern infrastructure, including 13 air handling units, separate processing areas, and quality control systems. The facility is GMP, WHO-GMP, FSSC 22000, ISO 9001:2015, ISO 45001:2018, and Halal certified, with an FSSAI license.
Competitive Strengths
- Experienced promoters and management Team
- Diverse product portfolio
- Commitment to quality standards
- Relationships with clients and suppliers
- Established business process and management framework